CASP3 and breast carcinoma: TRPV3 inhibition (TRPV3 siRNA) exert its pro-apoptotic activity (the number of apoptotic positive cells and caspase-3 activity were remarkably increased), anti-migration and anti-proliferation, and cell viability decreased in breast cancer cells.